Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system
No. | 75 |
---|---|
Citation | Blood Adv 4 (21): 5501-5511(2020) |
Institute | Hamamatsu University School of Medicine |
1st Author | Y Suzuki |
AR | 〇 (240/s) |
PL | |
HD | |
Paper types | Basic research |
Main purpose | Evaluation of the role of thrombin-activatable fibrinolysis inhibitor (TAFI) |
Disease | |
Antiplatelet drug | |
Anticoagulant drug | |
Other drug | tPA, TAFIa inhibitor |
Clinical specimens | |
Animal | |
Keyword | tissue-type plasminogen activator, tPA, thrombin-activatable fibrinolysis inhibitor, TAFI |